Syndax Pharmaceuticals, Inc. (SNDX)
Market Open
26 Oct, 06:13 PM
$
13. 30
-0.1
-0.7463%
$
1.2B Market Cap
- P/E Ratio
- Div Yield
926,052 Volume
-2.96 Eps
$ 13.4
Previous Close 
Want to track SNDX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Syndax Pharmaceuticals, Inc. (SNDX) Statistics
Valuation metrics
Market Cap 1.2B
Enterprise value 1.45B
Trailing P/E (ttm) -5.32
Forward P/E -90.26
PEG ratio -0.11
Price/Sales (ttm) 4.75
Price/Book (mrq) 78.98
Enterprise Value/Revenue 5.75
Enterprise Value/EBITDA -10.72
Overview
Shares outstanding 88.54M
Float 75.1M
Shares short 19.91M
% Held by insiders 0.02%
% Held by institutions 1.16%
Average volume (10 days) 2.94M
Average volume (90 days) 1.82M
Price summary
52-Week low 12.79
52-Week high 25.59
Beta 0.41
50-Day moving average 16.87
200-Day moving average 19.77
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -0.88%
Operating margin -0.77%
Operational effectiveness
Return on assets -0.31%
Return on equity -3.73%
Income Statement
Revenue (ttm) 217.17M
Revenue per share (ttm) 2.83
Quarterly revenue growth (yoy) 2.24%
Gross profit (ttm) -50.33M
EBITDA -224.17M
Net income to common (ttm) -243.25M
Diluted EPS (ttm) -2.48
Quarterly earnings growth (yoy) 2.24%
Balance Sheet
Total cash (mrq) 361.24M
Total cash per share (mrq) 6.16
Total debt (mrq) 345.36M
Total Debt/Equity (mrq) 39.03
Current ratio (mrq) 6.77%
Book value per share (mrq) 0.17
Cash Flow
Cash flow statement -278.16M
Levered free cash flow (LFCF) -186.26M
2026 © Marketlog. All Rights Reserved.
